This spring UMass Lowell Department of Chemical Engineering, and the UML’s Massachusetts Biomanufacturing Center received funding through the Massachusetts Life Science Center “Building Breakthroughs” program. The funding will support continuous bioprocessing manufacturing as an alternative to batch manufacturing. This new process is being explored in the manufacturing of small molecule drugs by the pharmaceutical industry. The research grant is part of a consortium that includes the M2D2 resident company (and 2018 $200K Challenge finalist) Versatope Therapeutics, who have developed an exosome-like vesicle technology currently used for vaccines. With this funding, these organizations are creating a truly transformative “continuous manufacturing” process for biopharmaceutical manufacturing. Continue reading →

We’re thrilled to spread the word that one of our innovative resident companies, LivOnyx, has been named one of five 2019 winners in the Massachusetts Life Sciences Center (MSLC) Massachusetts Next Generation Initiative. LivOnyx will receive $87,500 in funding, as well as access for a year to a network of executive coaches.